News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

After Its Drop, Is Aurinia (AUPH) Stock Now A Buy?



7/13/2017 6:14:33 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Aurinia Pharmaceuticals (NASDAQ:AUPH) could eventually change how doctors treat kidney failure in lupus patients. If so, buying shares, which have fallen significantly from their peak in March, could prove profit-friendly. Is this stock about to go higher?

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES